North America holds a dominant share of the global cough suppressants market, driven by the high prevalence of respiratory illnesses, well-established healthcare infrastructure, and strong consumer awareness regarding cough and cold management. The region experiences a significant number of cases related to seasonal influenza, allergies, asthma, and chronic respiratory diseases each year,...